Skip to main content

Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin’s lymphoma

Journal of Cancer Research and Clinical Oncology volume 135, pages 1473–1481 (2009)Cite this article

Abstract

Purpose

Vascular endothelial growth factor (VEGF) plays an important role in tumor angiogenesis and cancer progression. The VEGF genetic polymorphisms were shown to be independently associated with an adverse outcome in various malignancies. We investigated the possible associations of two polymorphisms (−2578C/A and +936C/T) in the VEGF gene with the clinicopathologic parameters for patients with non-Hodgkin’s lymphoma (NHL).

Methods

We studied the genotype and allele frequencies of the −2578C/A and +936C/T polymorphism in DNA samples of 431 patients with NHL using restriction fragment length polymorphism typing analysis.

Results

The −2578A allele was significantly associated with less frequent clinical staging III, IV and bone marrow involvement (The odds ratio (OR) 0.59; 95% confidence interval (CI) 0.43–0.82; and OR 0.66; 95% CI 0.48–0.91, respectively). The CA and CA + AA genotype of the −2578C/A were significantly associated with less frequent bone marrow involvement than CC genotypes (OR 0.57; 95% CI 0.38–0.86; and OR 0.57; 95% CI 0.39–0.85, respectively). The TT genotype of the +936C/T polymorphism was significantly associated with less frequent T cell histological type, clinical staging III, IV and bone marrow involvement (OR 0.25; 95% CI 0.07–0.89; OR 0.37; 95% CI 0.15–0.89; and OR 0.31; 95% CI 0.10–0.96, respectively). The +936 T allele was marginally associated with less frequent bone marrow involvement and with Clinical staging III, IV (OR 0.71; 95% CI 0.49–1.01; and OR 0.70; 95% CI 0.49–1.00, respectively). None of the evaluated genotypes of −2578C/A was significantly associated with the gender, age, tumor size, B symptoms and immunohistological subtype. No significant associations between the genotype of +936C/T and the clinicopathologic variables, gender, age, tumor size and B symptoms were ascertained. Both of the −2578C/A and +936C/T polymorphisms were not related to the patients’ overall survival.

Conclusion

We present the first data on VEGF gene polymorphisms in NHL. Our findings support the hypothesis that the −2578 CA and CA + AA and +936 TT VEGF genotypes and −2578A and +936T alleles are associated with decreased risk for invasion. But the investigated VEGF gene polymorphisms were not associated with prognosis in patients with NHL.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  • Dong X, Han ZC, Yang R (2007) Angiogenesis and antiangiogenic therapy in hematologic malignancies. Crit Rev Oncol Hematol 62:105–118

    PubMed  Article  Google Scholar 

  • Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4–25

    PubMed  Article  CAS  Google Scholar 

  • Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669–676

    PubMed  Article  CAS  Google Scholar 

  • Ganjoo KN, Moore AM, Orazi A, Sen JA, Johnson CS, An CS (2007) The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients. J Cancer Res Clin Oncol 134:381–387

    PubMed  Article  Google Scholar 

  • Hazar B, Paydas S, Zorludemir S, Sahin B, Tuncer I (2003) Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin’s lymphoma. Leuk Lymphoma 44:2089–2093

    PubMed  Article  CAS  Google Scholar 

  • Hefler LA, Mustea A, Könsgen D, Concin N, Tanner B, Strick R, Heinze G, Grimm C, Schuster E, Tempfer C, Reinthaller A, Zeillinger R (2007) Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer. Clin Cancer Res 13:898–901

    PubMed  Article  CAS  Google Scholar 

  • Ho CL, Sheu LF, Li CY (2002) Immunohistochemical expression of basic fibroblast growth factor, vascular endothelial growth factor, and their receptors in stage IV non-Hodgkin lymphoma. Appl Immunohistochem Mol Morphol 10:316–321

    PubMed  Article  CAS  Google Scholar 

  • Ho CL, Sheu LF, Li CY (2003) Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma. Ann Diagn Pathol 7:1–8

    PubMed  Article  Google Scholar 

  • Howell WM, Bateman AC, Turner SJ, Collins A, Theaker JM (2002) Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumor development in cutaneous malignant melanoma. Genes Immun 3:229–232

    PubMed  Article  CAS  Google Scholar 

  • Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, Henriksson R, Chen B, Pamula J, Pekala W, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Hallmans G, Försti A (2005) Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 11:3647–3653

    PubMed  Article  CAS  Google Scholar 

  • Jorgensen JM, Sorensen FB, Bendix K, Nielsen JL, Olsen ML, Funder AM, d’Amore F (2007) Angiogenesis in non-Hodgkin’s lymphoma: clinico-pathological correlations and prognostic significance in specific subtypes. Leuk Lymphoma 48:584–595

    PubMed  Article  CAS  Google Scholar 

  • Kataoka N, Cai Q, Wen W, Shu XO, Jin F, Gao YT, Zheng W (2006) Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev 15:1148–1152

    PubMed  Article  CAS  Google Scholar 

  • Kawai Y, Sakano S, Korenaga Y, Eguchi S, Naito K (2007) Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas. Eur Urol 52:1147–1155

    PubMed  Article  CAS  Google Scholar 

  • Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ, Kang JW, Lee SC, Jun Wee J, Kim WJ (2005) Genotypes of TNF-a, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. Urology 65:70–75

    PubMed  Article  Google Scholar 

  • Koster A, van Krieken JH, Mackenzie MA, Schraders M, Borm GF, van der Laak JA, Leenders W, Hebeda K, Raemaekers JM (2005) Increased vascularization predicts favorable outcome in follicular lymphoma. Clin Cancer Res 11:154–161

    PubMed  CAS  Google Scholar 

  • Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E, Sivridis E (2004) VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 46:293–298

    PubMed  Article  Google Scholar 

  • Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Haas J, Samonigg H (2003) A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 106:468–471

    PubMed  Article  CAS  Google Scholar 

  • Lee SJ, Lee SY, Jeon HS, Park SH, Jang JS, Lee GY, Son JW, Kim CH, Lee WK, Kam S, Park RW, Park TI, Kang YM, Kim IS, Jung TH, Park JY (2005) Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 14:571–575

    PubMed  Article  CAS  Google Scholar 

  • Marcus R (2005) Use of 90Y-ibritumomab tiuxetan in non-Hodgkin’s lymphoma. Semin Oncol 32:36–43

    Article  Google Scholar 

  • McCarron SL, Edwards S, Evans PR, Gibbs R, Dearnaley DP, Dowe A, Southgate C, Easton DF, Eeles RA, Howell WM (2002) Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 62:3369–3372

    PubMed  CAS  Google Scholar 

  • Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215

    PubMed  Article  CAS  Google Scholar 

  • Polterauer S, Grimm C, Mustea A, Concin N, Tanner B, Thiel F, Heinze G, Reinthaller A, Zeillinger R, Hefler LA (2007) Vascular endothelial growth factor gene polymorphisms in ovarian cancer. Gynecol Oncol 105:385–389

    PubMed  Article  CAS  Google Scholar 

  • Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E (2000) A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37:443–448

    PubMed  Article  CAS  Google Scholar 

  • Salven P, Orpana A, Teerenhovi L, Joensuu H (2000) Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients. Blood 96:3712–3718

    PubMed  CAS  Google Scholar 

  • Schneider BP, Radovich M, Sledge GW, Robarge JD, Li L, Storniolo AM, Lemler S, Nguyen AT, Hancock BA, Stout M, Skaar T, Flockhart DA (2007) Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat 113:197–198

    Google Scholar 

  • Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW (2003) Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 68:812–816

    Google Scholar 

  • Tzanakis N, Gazouli M, Rallis G, Giannopoulos G, Papaconstantinou I, Theodoropoulos G, Pikoulis E, Tsigris C, Karakitsos P, Peros G, Nikiteas N (2006) Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol 94:624–630

    PubMed  Article  CAS  Google Scholar 

  • Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12:1232–1235

    PubMed  Article  CAS  Google Scholar 

  • Yapijakis C, Vairaktaris E, Vassiliou S, Vylliotis A, Nkenke E, Nixon AM, Derka S, Spyridonidou S, Vorris E, Neukam F, Patsouris E (2007) The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer. J Cancer Res Clin Oncol 133:787–791

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported in part by the institution of higher learning strong and special subjects item Foundation, Hebei province, China.

Conflict of Interest Statement

We have not conflict of interest statement with anyone and institutes.

Author information

Affiliations

  1. Department of Hematology, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, 050011, China

    Lan-Ping Diao, Yu-Huan Gao, Hai-Sheng Liu, Li-Hong Liu & Li-Li Wu

  2. Chengde Central Hospital, Chengde, 067000, China

    Xiao-Ming Yu

  3. Laboratory of Molecular Biology, Hebei Cancer Institute, Shijiazhuang, 050011, China

    Yan Li, Rong-Miao Zhou & Na Wang

  4. Department of Surgery, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, 050011, China

    Shi-Jie Wang

Authors
  1. Lan-Ping Diao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiao-Ming Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu-Huan Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hai-Sheng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Li-Hong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rong-Miao Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Na Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Li-Li Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shi-Jie Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shi-Jie Wang.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Diao, LP., Yu, XM., Gao, YH. et al. Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin’s lymphoma. J Cancer Res Clin Oncol 135, 1473–1481 (2009). https://doi.org/10.1007/s00432-009-0650-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-009-0650-0

Keywords

  • VEGF
  • Genotype
  • Alleles
  • Non-Hodgkin’s lymphoma
  • Polymorphism